Hiru Corporation (HIRU)

[ddblock808]

Hiru Corporation (HIRU) Hosts Major Product Promotion in Northern China

Press Release Source: Hiru Corporation On Tuesday February 22, 2011, 3:45 pm EST
HENDERSON, NEVADA--(Marketwire - 02/22/11) - Hiru Corporation (PINK SHEETS:HIRU - News) (HIRU Corporation) subsidiary Jiangxi Shuangshi Animal Health Products Co.'s (Shuangshi AHP) sales department and after-sales customer service departments recently hosted a major successful product promotion in northern China.

The product promotion took place in Harbin, a city in the center of north-eastern China. This event has gained strong responses from the three major provinces in the area: Liaoning, Jilin and Heilongjiang. The region is rich in forest and animal resources and offers advantages in forestry and animal husbandry products. The region is also one of the main crops production base of China, with the large percentage of the national corn and soybean output.

The company noted a large number of participants to the company promotional fair. Shuangshi management is pleased with the success of the promotion and expects to further foster the company relationships in the province, expand, and deliver more products and solutions to this market locale in the future.

The company intends to provide further details on a timely basis to its followers.

[ddblock808]

Hiru Corporation (HIRU) Updates on the Company Research and Development

Press Release Source: Hiru Corporation On Friday February 25, 2011, 3:45 pm EST
HENDERSON, NEVADA--(Marketwire - 02/25/11) - Hiru Corporation (PINK SHEETS:HIRU - News) (HIRU Corporation) subsidiary Jiangxi Shaungshi AHP recently held training seminars in Beijing, China.

Five key technicians from HIRU's Jiangxi Shaungshi AHP's quality assurance department and research institute took part in the training seminars about UV, atomic absorption and liquid instrument held by Beijing Puxi General Instrument Co., Ltd.

Jiangxi Shaungshi R&D Center has developed a large number of market-oriented veterinary drugs, and the company's R&D center is a vital part of the company. The company management sees great potential in its current R&D endeavours and expects the knowledge increase to further the company's product development. The company R&D professionals reported that the seminars were well-received and see great potential in the new technology knowledge acquired.

[ddblock808]

Jiangxi Tianyun Agricultural Development Co., Ltd. (HIRU) Additional Agricultural Production Expansion

Press Release Source: Hiru Corporation On Friday March 4, 2011, 3:45 pm EST
HENDERSON, NEVADA--(Marketwire - 03/04/11) - Hiru Corporation (PINK SHEETS:HIRU - News) (HIRU Corporation) subsidiary Jiangxi Shuangshi Animal Health Products Co. and its Jiangxi Tianyun Agricultural Development Co., Ltd. are expanding into the poultry market by building a farm to raise chickens. Jiangxi Tianyun Agricultural Development Co., Ltd. focuses on executing Shuangshi's agricultural and animal husbandry expansion, and feels that poultry is a lucrative market right now.

China's poultry industry has increased exponentially over the last two decades. The rise in poultry consumption is due to rising incomes and the lower cost of poultry products. According to China's Ministry of Statistics, the poultry consumption alone increased from 7.5 pounds per capita in 1990, to 18.3 pounds per capita in 2006, a spike of 244% in China's cities, while in the urban areas it increased from 2.75 pounds per capita in 1990 to 7.7 pounds per capita in 2006, an increase of 281%, and this growth trend is expected to continue.

Jiangxi Tianyun Agricultural Development Co., Ltd. focuses on execution of Shuangshi's agricultural/animal husbandry expansions, securing company's diversity and steady growth. HIRU management is pleased with the expansion of its subsidiary and looks forward to future developments.

[ddblock808]

Shaungshi AHP (HIRU): Further Development in Company's R&D

Press Release Source: Hiru Corporation On Tuesday March 8, 2011, 3:45 pm EST
HENDERSON, NEVADA--(Marketwire - 03/08/11) - Hiru Corporation (PINK SHEETS:HIRU - News)(HIRU Corporation) following the news from March 1, 2011 subsidiary Jiangxi Shaungshi AHP has announced that two additional company's veterinary products have passed Chinese government testing.

Jiangxi Shaungshi AHP received a report from the Chinese Ministry of Agriculture with notification that the two products Shaungshi AHP had submitted for testing passed inspection and have obtained approval documents, stating that they meet mandatory GB Standards. These Chinese national standards are issued by the Standardization Administration of China (SAC), the Chinese National Committee of the ISO and IEC (International Electrotechnical Commission).

The two approved veterinary products are:


-- Sulfadiazine Sodium Injection (Veterinary Drug # 0704023493)-- Sulfamonomethoxine Sodium Injection (Veterinary Drug # 070423494)
Jiangxi Shaungshi AHP expects these products to enhance the company's already extensive portfolio. It will start producing and marketing these products to Chinese farmers shortly. The company's research and development center has been hard at work and expects to bring more products into the Chinese market.

[ddblock808]

Jiangxi Tianyun Agricultural Development Co., Ltd. (HIRU) Launches Additional Agricultural Expansions

Press Release Source: Hiru Corporation On Thursday March 10, 2011, 4:25 pm EST
HENDERSON, NEVADA--(Marketwire - 03/10/11) - Hiru Corporation (PINK SHEETS:HIRU - News) (HIRU Corporation) subsidiary Jiangxi Shuangshi Animal Health Products Co. updates on the company's development in the agricultural expansion. Following news on company's Jiangxi Tianyun Agricultural Development Co., Ltd. expanding into the poultry and herbal markets in China, the company is also launching a greenhouse vegetable venture to supply the growing Chinese food market.

Jiangxi Tianyun Agricultural Development Co., Ltd. was established with a registered initial capital of 2 million RMB (circa 300,000 USD) between Shuangshi AHP and its parent company Jiangxi Chuangdao Animal Health Product Co., Ltd. This venture has been most active in the agricultural development and HIRU management expects this newest agricultural expansion of this venture to bring solid market results.

Jiangxi Tianyun Agricultural Development Co., Ltd. focuses on execution of Shuangshi's agricultural/animal husbandry expansions, securing company's diversity and steady growth. HIRU management is pleased with the expansion of its subsidiary and looks forward to future developments.

[mickymoose99]

MindUp BioResearch (HIRU) Research Team Published Their New Results on the Topic of Overcoming Multiple-Drug Resistance in Lung Cancer Therapy



tweet
Email
Print
..



Companies:
Hiru Corporation

.




Related Quotes




Symbol

Price

Change




HIRU.PK

0.0004

0.00









Press Release Source: Hiru Corporation On Thursday August 4, 2011, 3:45 pm EDT


BELGRADE, SERBIA--(Marketwire -08/04/11)- Hiru Corporation (PINK SHEETS: HIRU.PK - News) (HIRU Corporation), is pleased to announce that researchers from its MindUp BioResearch (Homepage | MindUp BioResearch), European subsidiary have published their new results of preclinical studies on the topic of overcoming multidrug resistance, a frequent phenomenon occurring in cancer that seriously limit the efficacy of lung cancer course of therapy with chemotherapeutic agents.

Dr Sabera Ruzdijic, the Leader of MindUp Bioresearch Group said: "In this paper we examined the effect of two purine analogs sulfinosine (SF) and 8-Cl-cAMP on cell growth inhibition in parental and resistant human lung carcinoma cell lines. Pretreatment with purine analogues was more potent in improving the sensitivity of resistant lung carcinoma cells to doxorubicin than conventional chemo-sensitizing agent - verapamil (VER). Combinations of either SF or 8-Cl-cAMP with VER at clinically acceptable concentrations exhibited synergistic effects on cell growth inhibition in the resistant lung carcinoma cell line. Together with their ability to reverse multidrug resistance, these results render the purine analogs (in combination with VER) as potential candidates for improving the clinical activity of existing lung cancer therapeutics.

Dr Sabera Ruzdijic added: "We are proud that these results are accepted and published in the prestigious journal Investigational New Drugs (2010) 28:482-492 by Pesic et al. (http://www.springerlink.com/content/w2h2805230314332/)". At the company website HIRU Corporation you can find the PDF of article.

[smartinvest22]

HIRU dipped on open, grab those 0.0003's NOW and wait for the new momentum tide and triple your ROI! HIRU THE NEXT BOTTOM BREAKOUT PLAY!!

[smartinvest22]

HIRU latest MindUP research reveals the results of a study wherein a certain phenomenon occurs which not only inhibits the growth of lung cells but also reverses it! Everything's just fine on all ends, on top of that all HIRU got a production approval for 2 new vaccines by their China FDA, they recently put $450,000 back into R&D, they're penetrating into other venues to boost their revenues and yet they're acquiring new companies!

[smartinvest22]

HIRU Due Diligence! HIRU is grossly undervalued that I can't think from the top of my head of any reason for being so:
- Shuangshi (HIRU) to acquire a breeding farm
- to set up a poultry farm themselves
- 2 new animal vaccines production approval
- even one more approval for 2 new vaccines production came in March
- aggressive marketing and deeper penetration into nearby provinces
- Shuangshi (HIRU) expands into aquaculture
- Shuangshi (HIRU) puts $450,000 back into research and development,
- HIRU (MindUP) research found a way of reversing the growth of lung cancer cells. PUT HIRU ON YOUR WATCHLIST NOW!!!

[jeffjarret]

Discovering the most profitable positions and knowing which undiscovered stocks are poised to generate massive investor awareness and generate large amounts of money flow into a specific stock. - HOTTESTPICKS DOT NET